GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANWA) » Definitions » Pre-Tax Income

Immuron (FRA:ANWA) Pre-Tax Income : €-2.39 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Immuron Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Immuron's pretax income for the six months ended in Dec. 2023 was €-1.27 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-2.39 Mil. Immuron's pretax margin was -87.97%.

During the past 9 years, Immuron's highest Pretax Margin was -108.50%. The lowest was -5742.47%. And the median was -268.66%.


Immuron Pre-Tax Income Historical Data

The historical data trend for Immuron's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron Pre-Tax Income Chart

Immuron Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only -2.86 -1.79 -5.32 -1.90 -2.35

Immuron Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.15 -0.69 -1.26 -1.12 -1.27

Competitive Comparison of Immuron's Pre-Tax Income

For the Biotechnology subindustry, Immuron's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuron's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuron's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Immuron's Pre-Tax Income falls into.



Immuron Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Immuron's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.111+-0.302+-0.006+0.072+0.00099999999999989
=-2.35

Immuron's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.779+-0.585+-0.002+0.095+-0.00099999999999989
=-1.27

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immuron  (FRA:ANWA) Pre-Tax Income Explanation

Immuron's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-1.272/1.446
=-87.97%

During the past 9 years, Immuron's highest Pretax Margin was -108.50%. The lowest was -5742.47%. And the median was -268.66%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immuron Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Immuron's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Immuron (FRA:ANWA) Business Description

Traded in Other Exchanges
Address
Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Immuron (FRA:ANWA) Headlines

No Headlines